These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9212953)
41. In vitro investigation of the St. Jude Medical Isoflow centrifugal pump: flow visualization and hemolysis studies. Mulder MM; Hansen AC; Mohammad SF; Olsen DB Artif Organs; 1997 Aug; 21(8):947-53. PubMed ID: 9247185 [TBL] [Abstract][Full Text] [Related]
43. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass? Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305 [TBL] [Abstract][Full Text] [Related]
44. Platelet function and hemolysis in centrifugal pumps: in vitro investigations. Steines D; Westphal D; Göbel C; Reul H; Rau G Int J Artif Organs; 1999 Aug; 22(8):559-65. PubMed ID: 10533912 [TBL] [Abstract][Full Text] [Related]
45. Effect of surface roughness on hemolysis in a pivot bearing supported Gyro centrifugal pump (C1E3). Takami Y; Makinouchi K; Nakazawa T; Glueck J; Benkowski R; Nosé Y Artif Organs; 1996 Nov; 20(11):1155-61. PubMed ID: 8908324 [TBL] [Abstract][Full Text] [Related]
46. The hemolysis test of the Gyro C1E3 pump in pulsatile mode. Tayama E; Nakazawa T; Takami Y; Makinouchi K; Ohtsubo S; Ohashi Y; Andrade AJ; Glueck J; Mueller J; Nosé Y Artif Organs; 1997 Jul; 21(7):675-9. PubMed ID: 9304391 [TBL] [Abstract][Full Text] [Related]
47. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass. Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892 [TBL] [Abstract][Full Text] [Related]
48. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148 [TBL] [Abstract][Full Text] [Related]
49. Experimental use of a compact centrifugal pump and membrane oxygenator as a cardiopulmonary support system. Suenaga E; Naito K; Cao ZL; Suda H; Ueno T; Natsuaki M; Itoh T Artif Organs; 2000 Nov; 24(11):912-5. PubMed ID: 11119082 [TBL] [Abstract][Full Text] [Related]
50. Centrifugal pump and roller pump in adult cardiac surgery: a meta-analysis of randomized controlled trials. Saczkowski R; Maklin M; Mesana T; Boodhwani M; Ruel M Artif Organs; 2012 Aug; 36(8):668-76. PubMed ID: 22804106 [TBL] [Abstract][Full Text] [Related]
51. Experimental studies on three types of heparin-coated cardiopulmonary bypass circuits. Baba T; Morisita K; Sakata J; Ito T; Hachiro Y; Kazui T; Abe A; Komatu S Artif Organs; 1997 Jul; 21(7):779-81. PubMed ID: 9212957 [TBL] [Abstract][Full Text] [Related]
53. Systemic inflammation and cardiac surgery: an update. Asimakopoulos G Perfusion; 2001 Sep; 16(5):353-60. PubMed ID: 11565890 [TBL] [Abstract][Full Text] [Related]
54. Clinical evaluation of the Gyro Pump C1E3 as a cardiopulmonary bypass pump. Orime Y; Shiono M; Yagi S; Yamamoto T; Okumura H; Kimura S; Hata M; Sezai A; Kashiwazaki S; Choh S; Negishi N; Sezai Y; Matsui T; Suzuki M ASAIO J; 2000; 46(1):128-33. PubMed ID: 10667731 [TBL] [Abstract][Full Text] [Related]
55. Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit. Moen O; Fosse E; Bråten J; Andersson C; Høgåsen K; Mollnes TE; Venge P; Kierulf P Perfusion; 1996 Mar; 11(2):113-23. PubMed ID: 8740352 [TBL] [Abstract][Full Text] [Related]
56. Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass. Khan MM; Gikakis N; Miyamoto S; Rao AK; Cooper SL; Edmunds LH; Colman RW Ann Thorac Surg; 1999 Aug; 68(2):473-8. PubMed ID: 10475415 [TBL] [Abstract][Full Text] [Related]
57. Pulsatile compared with nonpulsatile perfusion using a centrifugal pump for cardiopulmonary bypass during coronary artery bypass grafting. Effects on systemic haemodynamics, oxygenation, and inflammatory response parameters. Driessen JJ; Dhaese H; Fransen G; Verrelst P; Rondelez L; Gevaert L; van Becelaere M; Schelstraete E Perfusion; 1995; 10(1):3-12. PubMed ID: 7795311 [TBL] [Abstract][Full Text] [Related]
58. Influence of hepatic mitochondrial redox state on complement biosynthesis and activation during and after cardiopulmonary bypass operations. Nomoto S; Shimahara Y; Kumada K; Okamoto Y; Ban T Eur J Cardiothorac Surg; 1996; 10(4):273-8. PubMed ID: 8740064 [TBL] [Abstract][Full Text] [Related]
59. Centrifugal pumps: description of devices and surgical techniques. Curtis JJ; Walls JT; Wagner-Mann CC; Schmaltz RA; Demmy TL; McKenney CA; Mann FA Ann Thorac Surg; 1999 Aug; 68(2):666-71. PubMed ID: 10475468 [TBL] [Abstract][Full Text] [Related]
60. Pharmacological prevention of the deleterious effects of cardiopulmonary bypass. Hassantash SA; Omrani GR; Givtaj N; Afrakhteh M Asian Cardiovasc Thorac Ann; 2007 Jun; 15(3):218-24. PubMed ID: 17540991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]